Jianxu Sun , Ge Gao , Sitong Wang , Hongmei Liu , Tie-Shan Tang
{"title":"Decoding the influence of mitochondrial Ca2+ regulation on neurodegenerative disease progression","authors":"Jianxu Sun , Ge Gao , Sitong Wang , Hongmei Liu , Tie-Shan Tang","doi":"10.1016/j.mitoco.2025.01.001","DOIUrl":null,"url":null,"abstract":"<div><div>Mitochondria are pivotal hubs in maintaining cellular homeostasis, encompassing vital processes such as bioenergetics, redox regulation, Ca<sup>2+</sup> signaling, and programmed cell death. Ca<sup>2+</sup> is a key second messenger within cells, paramount in numerous critical biological processes. The maintenance of mitochondrial calcium homeostasis relies on a delicate balance between Ca<sup>2+</sup> uptake and efflux. At the mitochondrial level, Ca<sup>2+</sup> serves a dual function, participating in essential physiological processes such as ATP production and the regulation of mitochondrial metabolisms and contributing to pathophysiological events, including cell death and cancer metastasis. Alterations in mitochondrial Ca<sup>2+</sup> (Ca<sup>2+</sup><sub>mito</sub>) levels influence cellular activity and functionality. The regulation of mitochondrial Ca<sup>2+</sup> homeostasis involves the collaborative participation of the mitochondrial Ca<sup>2+</sup> transporter and the mitochondria-endoplasmic reticulum contact sites (MERCS). This review provides a comprehensive overview of current knowledge regarding the regulation of mitochondrial Ca<sup>2+</sup> homeostasis and its implications in both physiological processes and neurodegenerative disorders. Moreover, we highlight potential opportunities and challenges in developing therapeutic interventions that target mitochondrial Ca<sup>2+</sup> homeostasis and its regulators, such as novel drug delivery systems and specific calcium-modulating agents.</div></div>","PeriodicalId":100931,"journal":{"name":"Mitochondrial Communications","volume":"3 ","pages":"Pages 1-15"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mitochondrial Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S259027922500001X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Mitochondria are pivotal hubs in maintaining cellular homeostasis, encompassing vital processes such as bioenergetics, redox regulation, Ca2+ signaling, and programmed cell death. Ca2+ is a key second messenger within cells, paramount in numerous critical biological processes. The maintenance of mitochondrial calcium homeostasis relies on a delicate balance between Ca2+ uptake and efflux. At the mitochondrial level, Ca2+ serves a dual function, participating in essential physiological processes such as ATP production and the regulation of mitochondrial metabolisms and contributing to pathophysiological events, including cell death and cancer metastasis. Alterations in mitochondrial Ca2+ (Ca2+mito) levels influence cellular activity and functionality. The regulation of mitochondrial Ca2+ homeostasis involves the collaborative participation of the mitochondrial Ca2+ transporter and the mitochondria-endoplasmic reticulum contact sites (MERCS). This review provides a comprehensive overview of current knowledge regarding the regulation of mitochondrial Ca2+ homeostasis and its implications in both physiological processes and neurodegenerative disorders. Moreover, we highlight potential opportunities and challenges in developing therapeutic interventions that target mitochondrial Ca2+ homeostasis and its regulators, such as novel drug delivery systems and specific calcium-modulating agents.